Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

HealthLynked (HLYK) Accumulated Depreciation & Amortization (2016 - 2025)

HealthLynked (HLYK) has disclosed Accumulated Depreciation & Amortization for 10 consecutive years, with $728710.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 14.79% to $728710.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $728710.0 through Dec 2025, up 14.79% year-over-year, with the annual reading at $728710.0 for FY2025, 14.79% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $728710.0 at HealthLynked, up from $702256.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $728710.0 in Q4 2025, with the low at $204353.0 in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $472272.5, with a median of $474660.0 recorded in 2023.
  • Peak annual rise in Accumulated Depreciation & Amortization hit 59.76% in 2021, while the deepest fall reached 73.53% in 2021.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $283512.0 in 2021, then soared by 40.1% to $397194.0 in 2022, then skyrocketed by 31.19% to $521062.0 in 2023, then increased by 21.84% to $634839.0 in 2024, then increased by 14.79% to $728710.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $728710.0, $702256.0, and $690101.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.